Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics
This review/opinion article (2023) suggests that the reversal of and resilience against learned helplessness could be a key therapeutic mechanism of classic psychedelics in treating mood and substance use disorders. The authors argue for the utility of the learned helplessness model in psychedelic research due to its robustness across species, well-described neurobiology, and substantial overlap with neural circuits involved in psychedelic actions.
Authors
- Frederick Barrett
- David Yaden
- Alaina Doss
Published
Abstract
Background: Emerging literature suggests that classic psychedelics may have efficacy in treating mood and substance use disorders in humans. This has raised questions regarding the primary therapeutic mechanism of these compounds. Here, we hypothesize that the reversal of and resilience against learned helplessness may be an important driver of the therapeutic mechanisms of classic psychedelics. Furthermore, we argue that the learned helplessness paradigm can provide a robust model to investigate the behavioral and mechanistic effects of classic psychedelics in both clinical and preclinical experiments.Opinion: We highlight the learned helplessness model and its potential utility in the psychedelic sphere for several reasons. First, learned helplessness is a robust phenomenon observed across multiple mammalian species including humans, and has been well described in terms of its neurobiology, behavioral effects, and clinical implications; current efforts in psychedelic research and theories of psychedelic mechanisms have yet to achieve this level of integration. Interestingly, there is substantial overlap in the neural circuits governing resilience against learned helplessness and psychedelic actions-such as those involving the dorsal raphe nucleus. Furthermore, our hypothesis that classic psychedelics can reverse helplessness behavior fits with much of the current preclinical data, which has shown that psychedelics improve performance in behavioral despair tasks in rodents. Here we make the case for bringing attention to these congruencies in an effort to advance toward mechanistic, behavioral, and transdiagnostic insights into the therapeutic effects of classic psychedelics, with the potential for learned helplessness to help explain some positive effects across levels of analysis.
Research Summary of 'Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics'
Introduction
Classic serotonergic psychedelics (5-HT2A receptor-mediated compounds such as psilocybin and LSD) have shown promising effects in mood and substance use disorders, but their primary therapeutic mechanisms remain unclear. Prior theoretical accounts have emphasised either neurobiological processes (for example, enhanced plasticity or reopening of critical-period-like windows) or psychological/subjective mechanisms (for example, mystical-type experiences, insight, psychological flexibility, and emotional breakthrough). Few frameworks have successfully integrated these levels of analysis, and existing neurobiological proposals lack specificity about which brain circuits and behaviours they target and how such changes map onto durable clinical benefit. This paper proposes that reversal of, and resilience against, learned helplessness could be a core transdiagnostic mechanism through which classic psychedelics exert therapeutic effects. The authors argue that the learned helplessness paradigm is well suited to bridge preclinical and clinical levels of analysis because it is robust across mammalian species, has well-described neural circuitry, and captures behavioural features that overlap with depressive and stress-related disorders. They set out to synthesise evidence from animal models, neurophysiology, imaging, and limited behavioural pharmacology to show congruence between the neural substrates of learned helplessness and the known effects of classic psychedelics, and to make the case for using learned helplessness as a productive model in future psychedelic research.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typemeta
- Journal
- Topics
- Authors
- APA Citation
Tiwari, P., Berghella, A. P., Sayalı, C., Doss, M. K., Barrett, F. S., & Yaden, D. B. (2023). Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics. Psychedelic Medicine, 1(2), 74-86. https://doi.org/10.1089/psymed.2023.0010
References (34)
Papers cited by this study that are also in Blossom
Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)
Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Sanches, R. F., Osório, F. L., Dos Santos, R. G. et al. · Journal of Clinical Psychopharmacology (2016)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Galvão-Coelho, N. L., Marx, W., Sinclair, J. et al. · Psychopharmacology (2021)
Ly, C., Greb, A. C., Cameron, L. P. et al. · Cell Reports (2018)
Olson, D. E. · ACS Pharmacology and Translational Science (2020)
Cameron, L. P., Tombari, R. J., Lu, J. et al. · Nature (2020)
Calder, A. E., Hasler, G. · Neuropsychopharmacology (2022)
Show all 34 referencesShow fewer
Nardou, R., Lewis, E. M., Rothhaas, R. et al. · Nature (2019)
Davis, A. K., Barrett, F. S., Griffiths, R. R. · Journal of Contextual Behavioral Science (2020)
Garcia-Romeu, A., Griffiths, R. R., Johnson, M. W. · Current Drug Abuse Reviews (2015)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Journal of Psychopharmacology (2017)
Yaden, D. B., Griffiths, R. R. · ACS Pharmacology and Translational Science (2020)
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Roseman, L., Haijen, E. C. H. M., Idialu-Ikato, K. et al. · Journal of Psychopharmacology (2019)
van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)
Geyer, M. A., Vollenweider, F. X. · Trends in Pharmacological Sciences (2008)
Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)
Doss, M. K., Madden, M. B., Gaddis, A. et al. · Brain (2021)
Barrett, F. S., Krimmel, S. R., Griffiths, R. R. et al. · NeuroImage (2020)
Barrett, F. S., Doss, M. K., Sepeda, N. D. et al. · Scientific Reports (2020)
Doss, M. K., Považan, M., Rosenberg, M. D. et al. · Translational Psychiatry (2021)
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Shao, L-X,, Liao, C., Gregg, I. et al. · Neuron (2021)
Marek, G. J. · Current Topics in Behavioral Neurosciences (2018)
Vollenweider, F. X., Leenders, K. L., Maguire, P. et al. · Neuropsychopharmacology (1997)
Lewis, C. R., Preller, K. H., Kraehenmann, R. et al. · NeuroImage (2017)
De Gregorio, D., Inserra, A., Enns, J. P. et al. · Neuropsychopharmacology (2022)
Kraehenmann, R., Preller, K. H., Scheidegger, M. et al. · Biological Psychiatry (2015)
Mueller, F., Lenz, C., Dolder, P. C. et al. · Translational Psychiatry (2017)
Kaplan, A. L., Confair, D. N., Kim, K. et al. · Nature (2022)
Cited By (1)
Papers in Blossom that reference this study
Yaden, D. B., Goldy, S. P., Weiss, B. et al. · Nature Reviews Psychology (2024)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.